Search Results - "Ding, Sentai"

Refine Results
  1. 1

    Different levels of estradiol are correlated with sexual dysfunction in adult men by Chen, Tong, Wu, Fei, Wang, Xianlong, Ma, Gang, Xuan, Xujun, Tang, Rong, Ding, Sentai, Lu, Jiaju

    Published in Scientific reports (29-07-2020)
    “…Ejaculatory dysfunction, including premature ejaculation (PE) and delayed ejaculation (DE), as well as erectile dysfunction (ED), constitute the majority of…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Expression of HER2 in high-grade urothelial carcinoma based on Chinese expert consensus and the clinical effects of disitamab vedotin-tislelizumab combination therapy in the treatment of advanced patients by Zhu, Kejia, Chang, Yao, Zhao, Delong, Guo, Andong, Cao, Jishuang, Wu, Chenrui, Guan, Yong, Ding, Sentai

    Published in Frontiers in pharmacology (22-02-2024)
    “…A vast number of researchers have discovered high levels of human epidermal growth factor receptor-2 (HER2) expression in urothelial carcinoma (UC), but they…”
    Get full text
    Journal Article
  4. 4

    Hypoxia activates the hypoxia-inducible factor-1α/vascular endothelial growth factor pathway in a prostatic stromal cell line: A mechanism for the pathogenesis of benign prostatic hyperplasia by Zhang, Tao, Mao, Changlin, Chang, Yao, Lyu, Jiaju, Zhao, Delong, Ding, Sentai

    Published in Current urology (01-09-2024)
    “…The development of benign prostatic hyperplasia (BPH) is closely related to hypoxia in the prostatic stroma, and the hypoxia-inducible factor-1α/vascular…”
    Get full text
    Journal Article
  5. 5

    A Potent Chemotherapeutic Strategy with Eg5 Inhibitor against Gemcitabine Resistant Bladder Cancer by Sun, Liang, Lu, Jiaju, Niu, Zhihong, Ding, Kejia, Bi, Dongbin, Liu, Shuai, Li, Jiamei, Wu, Fei, Zhang, Hui, Zhao, Zuohui, Ding, Sentai

    Published in PloS one (10-12-2015)
    “…Development of resistance to gemcitabine is a major concern in bladder cancer therapy, and the mechanism remains unclear. Eg5 has been recently identified as…”
    Get full text
    Journal Article
  6. 6

    Integrated Protein-Protein Interaction and Weighted Gene Co-expression Network Analysis Uncover Three Key Genes in Hepatoblastoma by Tian, Linlin, Chen, Tong, Lu, Jiaju, Yan, Jianguo, Zhang, Yuting, Qin, Peifang, Ding, Sentai, Zhou, Yali

    “…Hepatoblastoma (HB) is the most common liver tumor in the pediatric population, with typically poor outcomes for advanced-stage or chemotherapy-refractory HB…”
    Get full text
    Journal Article
  7. 7

    Overexpression of Eg5 predicts unfavorable prognosis in non-muscle invasive bladder urothelial carcinoma by Ding, Sentai, Xing, Naidong, Lu, Jiaju, Zhang, Hui, Nishizawa, Koji, Liu, Shuai, Yuan, Xiaodong, Qin, Yejun, Liu, Ying, Ogawa, Osuma, Nishiyama, Hiroyuki

    Published in International journal of urology (01-06-2011)
    “…Objective:  To investigate the relationship between Eg5 expression and prognosis of patients with non‐muscle invasive bladder urothelial carcinoma. Methods: …”
    Get full text
    Journal Article
  8. 8

    Efficacy of cytokine-induced killer therapy following operation of renal cell carcinoma in north China by Lv, Jiaju, Liu, Xiaoli, Fu, Qiang, Zhang, Keqin, Ding, Sentai, Song, Wanmei, Li, Xin, Zhang, Hui, Sun, Dingqi, Liu, Shuai

    Published in Journal of King Saud University. Science (01-12-2020)
    “…Purpose: The purpose of the study was to evaluate the antitumor activity of CIK cells in vitro and investigate the clinical efficacy of cytokine-induced killer…”
    Get full text
    Journal Article
  9. 9

    Dicoumarol enhances doxorubicin‐induced cytotoxicity in p53 wild‐type urothelial cancer cells through p38 activation by Matsui, Yoshiyuki, Watanabe, Jun, Ding, Sentai, Nishizawa, Koji, Kajita, Yoichiro, Ichioka, Kentaro, Saito, Ryoichi, Kobayashi, Takashi, Ogawa, Osamu, Nishiyama, Hiroyuki

    Published in BJU international (01-02-2010)
    “…OBJECTIVE To investigate the effectiveness of a combined treatment of 3–30‐methylene‐bis[4‐hydroxycoumarin] (dicoumarol) with doxorubicin for the treatment of…”
    Get full text
    Journal Article
  10. 10

    A potent chemotherapeutic strategy for bladder cancer: (S)-methoxy-trityl-L-cystein, a novel Eg5 inhibitor by Ding, Sentai, Nishizawa, Koji, Kobayashi, Takashi, Oishi, Shinya, Lv, Jiajv, Fujii, Nobutaka, Ogawa, Osamu, Nishiyama, Hiroyuki

    Published in The Journal of urology (01-09-2010)
    “…Eg5, which has an essential role in the formation and maintenance of a bipolar mitotic spindle, was recently identified as an attractive target in cancer…”
    Get more information
    Journal Article
  11. 11
  12. 12

    Immune checkpoint inhibitor therapy as a neoadjuvant treatment for muscle-invasive bladder carcinoma by Ding, Sentai, Lyu, Jiaju

    Published in Current urology (14-11-2024)
    “…Abstract Background and objectives Immunotherapy has become a standard treatment for patients with advanced urothelial carcinoma, and neoadjuvant immunotherapy…”
    Get full text
    Journal Article
  13. 13

    Uric acid mediates the association between testosterone and α-Klotho among males: results from the NHANES 2013–2016 by Guo, Andong, Cao, Jishuang, Wu, Chenrui, Ding, Sentai

    Published in International urology and nephrology (02-11-2024)
    “…This study initially conducted a cross-sectional analysis to examine the association between total testosterone (TT), uric acid, and Klotho. The investigation…”
    Get full text
    Journal Article
  14. 14

    Laparoscopy and ureteroscopy cooperative surgery for high burden stones in solitary kidney and ureter in one stage: A case report by Zhu, Kejia, Chang, Yao, Zhao, Delong, Guan, Yong, Ding, Sentai

    Published in Experimental and therapeutic medicine (01-06-2023)
    “…Treatment of kidney and ureter multiple calculi is a difficult procedure in urology. It is especially difficult to eliminate the high burden stones in a…”
    Get full text
    Journal Article
  15. 15

    Correlation analysis of survivin, ING4, CXCL8 and VEGF expression in prostate cancer tissue by Kong, Lingwei, Qi, Rushan, Zhou, Guangchun, Ding, Sentai

    Published in American journal of translational research (01-01-2021)
    “…This study aimed to investigate the expression of Survivin, inhibitor of growth 4 (ING4), CXC chemokine ligand 8 (CXCL8), vascular endothelial growth factor…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Metformin inhibits 17β-estradiol-induced epithelial-to-mesenchymal transition via βKlotho-related ERK1/2 signaling and AMPKα signaling in endometrial adenocarcinoma cells by Liu, Zhao, Qi, Shasha, Zhao, Xingbo, Li, Mingjiang, Ding, Sentai, Lu, Jiaju, Zhang, Hui

    Published in Oncotarget (19-04-2016)
    “…The potential role of metformin in treating endometrial cancer remains to be explored. The current study investigated the role of metformin in…”
    Get full text
    Journal Article
  18. 18

    Expression of HER2 in urothelial carcinoma and its significance by Chang, Yao, Zhao, Delong, Wang, Zicheng, Zhu, Kejia, Guo, Andong, Cao, Jishuang, Wu, Chenrui, Ding, Sentai

    Published in Current urology (27-05-2024)
    “…Abstract Objectives We explored the expression levels and clinical significance of human epidermal growth factor receptor 2 (HER2) in urothelial carcinoma (UC)…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Label-free quantitative proteomic analysis reveals potential biomarkers and pathways in renal cell carcinoma by Zhao, Zuohui, Wu, Fei, Ding, Sentai, Sun, Liang, Liu, Zhao, Ding, Kejia, Lu, Jiaju

    Published in Tumor biology (01-02-2015)
    “…Renal cell carcinoma (RCC) is one of the most common malignancies in adults, and there is still no acknowledged biomarker for its diagnosis, prognosis,…”
    Get full text
    Journal Article